Literature DB >> 15998434

Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.

Marie Fukushima1, Makoto Nakamuta, Motoyuki Kohjima, Kazuhiro Kotoh, Munechika Enjoji, Naoya Kobayashi, Hajime Nawata.   

Abstract

BACKGROUND/AIMS: The Rho-ROCK signaling pathways play an important role in the activation of hepatic stellate cells (HSCs). We investigated the effects of fasudil hydrochloride hydrate (fasudil), a Rho-kinase (ROCK) inhibitor, on cell growth, collagen production, and collagenase activity in HSCs.
METHODS: Rat HSCs and human HSC-derived TWNT-4 cells were cultured for studies on stress fiber formation and alpha-smooth muscle actin (alpha-SMA) expression. Proliferation was measured by BrdU incorporation, and apoptosis by TUNEL assay. The phosphorylation states of the MAP kinases (MAPKs), extra cellular signal -regulated kinase 1/2 (ERK1/2), c-jun kinase (JNK), and p38 were evaluated by western blot analysis. Type I collagen, matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) production and gene expression were evaluated by ELISA and real-time PCR, respectively. Collagenase activity (active MMP-1) was also evaluated.
RESULTS: Fasudil (100 microM) inhibited cell spreading, the formation of stress fibers, and expression of alpha-SMA with concomitant suppression of cell growth, although it did not induce apoptosis. Fasudil inhibited phosphorylation of ERK1/2, JNK, and p38. Treatment with fasudil suppressed the production and transcription of collagen and TIMP, stimulated the production and transcription of MMP-1, and enhanced collagenase activity.
CONCLUSION: These findings demonstrated that fasudil not only suppresses proliferation and collagen production but also increases collagenase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998434     DOI: 10.1111/j.1478-3231.2005.01142.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  15 in total

1.  Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease.

Authors:  Li Zhou; Fei Liu; Xiao R Huang; Fang Liu; Haiyong Chen; Arther C K Chung; Jianjian Shi; Lei Wei; Hui Y Lan; Ping Fu
Journal:  Am J Nephrol       Date:  2011-10-04       Impact factor: 3.754

2.  Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

Authors:  Hong Zhou; Yong-jun Li; Mian Wang; Li-hui Zhang; Bing-yan Guo; Zhan-sheng Zhao; Feng-ling Meng; Yong-gui Deng; Rui-ying Wang
Journal:  Acta Pharmacol Sin       Date:  2011-07-11       Impact factor: 6.150

3.  Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.

Authors:  Nilesh Gupta; Jahidur Rashid; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2017-02-17       Impact factor: 4.939

4.  Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction.

Authors:  Eric M Small; Jeffrey E Thatcher; Lillian B Sutherland; Hideyuki Kinoshita; Robert D Gerard; James A Richardson; J Michael Dimaio; Hesham Sadek; Koichiro Kuwahara; Eric N Olson
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

5.  Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures.

Authors:  Minnie Malik; Joy Britten; James Segars; William H Catherino
Journal:  Reprod Sci       Date:  2014-08-01       Impact factor: 3.060

6.  Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.

Authors:  M Hennenberg; J Trebicka; C Stark; A Z Kohistani; J Heller; T Sauerbruch
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

Review 7.  Rho kinase in the regulation of cell death and survival.

Authors:  Jianjian Shi; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-09       Impact factor: 4.291

Review 8.  Hepatic stellate cells as key target in liver fibrosis.

Authors:  Takaaki Higashi; Scott L Friedman; Yujin Hoshida
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 17.873

9.  Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.

Authors:  Marike Marjolijn van Beuge; Jai Prakash; Marie Lacombe; Eduard Post; Catharina Reker-Smit; Leonie Beljaars; Klaas Poelstra
Journal:  Pharm Res       Date:  2011-03-26       Impact factor: 4.200

10.  NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.

Authors:  Motoyuki Kohjima; Munechika Enjoji; Nobito Higuchi; Kazuhiro Kotoh; Masaki Kato; Ryoiichi Takayanagi; Makoto Nakamuta
Journal:  Liver Int       Date:  2007-11       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.